To corroborate whether abnormal expression of eIF5a is involved in the development and progression of human AAAs, we examined the expression level of eIF5a in the normal aorta, unruptured AAA, and ruptured AAA. The gene discussed is EIF5A; the disease is achalasia-alacrima syndrome.